Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +6.41% slipped 1.41% to $340.88 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +3.03% rising 0.00% to 15,235.84 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.40% falling 0.74% to 35,490.69. This was the stock's second consecutive day of losses. Moderna Inc. closed $156.61 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.13% fell 1.00% to $108.40, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.21% fell 1.01% to $206.58, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -1.17% fell 0.79% to $61.77. Trading volume (4.7 M) remained 8.3 million below its 50-day average volume of 13.0 M.